IRIS UniCatt

Richeldi, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.757
AS - Asia 8.011
EU - Europa 5.943
SA - Sud America 1.966
AF - Africa 285
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 10
Totale 25.036
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.391
SG - Singapore 3.646
BR - Brasile 1.615
CN - Cina 1.575
IT - Italia 1.542
SE - Svezia 1.013
VN - Vietnam 887
DE - Germania 583
FR - Francia 573
PL - Polonia 460
GB - Regno Unito 389
IE - Irlanda 334
ID - Indonesia 273
JP - Giappone 269
HK - Hong Kong 267
FI - Finlandia 265
IN - India 245
RU - Federazione Russa 203
CA - Canada 181
AR - Argentina 124
MX - Messico 124
BD - Bangladesh 118
KR - Corea 100
AT - Austria 95
NL - Olanda 93
IQ - Iraq 88
TR - Turchia 86
ZA - Sudafrica 66
UA - Ucraina 62
ES - Italia 60
SA - Arabia Saudita 58
BE - Belgio 57
PK - Pakistan 56
AU - Australia 50
EC - Ecuador 45
IR - Iran 45
CO - Colombia 43
MA - Marocco 41
VE - Venezuela 38
CH - Svizzera 36
CZ - Repubblica Ceca 32
JO - Giordania 32
EG - Egitto 31
PY - Paraguay 29
AE - Emirati Arabi Uniti 28
PH - Filippine 28
TN - Tunisia 28
CI - Costa d'Avorio 27
TW - Taiwan 27
LT - Lituania 26
PE - Perù 26
UZ - Uzbekistan 26
KE - Kenya 20
MY - Malesia 20
IL - Israele 19
UY - Uruguay 19
DZ - Algeria 17
RO - Romania 16
CL - Cile 15
PT - Portogallo 15
AZ - Azerbaigian 14
NZ - Nuova Zelanda 14
KZ - Kazakistan 13
ET - Etiopia 12
GR - Grecia 12
NP - Nepal 12
BO - Bolivia 11
CR - Costa Rica 11
TH - Thailandia 11
JM - Giamaica 9
AO - Angola 8
BG - Bulgaria 8
EU - Europa 8
OM - Oman 8
SN - Senegal 8
AL - Albania 7
HR - Croazia 7
KG - Kirghizistan 7
LB - Libano 7
MD - Moldavia 7
NO - Norvegia 7
PA - Panama 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
LK - Sri Lanka 6
NG - Nigeria 6
BY - Bielorussia 5
BZ - Belize 5
DO - Repubblica Dominicana 5
EE - Estonia 5
GA - Gabon 5
GE - Georgia 5
HN - Honduras 5
HU - Ungheria 5
LV - Lettonia 5
PS - Palestinian Territory 5
SD - Sudan 5
SY - Repubblica araba siriana 5
BH - Bahrain 4
CG - Congo 4
Totale 24.978
Salva come PNG Salva come JPEG
Città #
Singapore 1.916
San Jose 1.005
Ashburn 951
Chandler 675
Warsaw 433
Beijing 408
Rome 346
Fairfield 333
Dublin 331
Ho Chi Minh City 294
Milan 280
New York 244
Tokyo 238
Hong Kong 232
Jakarta 227
Lauterbourg 217
Hefei 206
Los Angeles 205
The Dalles 200
Hanoi 192
Wilmington 192
Helsinki 185
Dallas 175
Houston 167
Munich 158
Woodbridge 157
Boston 155
Princeton 148
Chicago 147
Seattle 147
São Paulo 147
Frankfurt am Main 138
San Mateo 136
St Louis 118
Council Bluffs 117
Moscow 116
Ann Arbor 106
Cambridge 95
Nuremberg 92
Santa Clara 75
London 74
Seoul 65
Boardman 64
Kent 64
North Bergen 61
Rio de Janeiro 58
Orem 57
Atlanta 52
Buffalo 50
Brussels 47
Paris 47
Brooklyn 45
Jacksonville 45
Mexico City 45
Da Nang 43
Marseille 43
Lappeenranta 41
Vienna 40
Denver 39
Toronto 38
Bremen 37
Montreal 37
Shanghai 37
Amsterdam 36
Stockholm 36
Augusta 34
Chennai 34
Amman 32
Johannesburg 32
Nanjing 31
Baghdad 30
Dhaka 30
Düsseldorf 30
Phoenix 30
Poplar 30
Belo Horizonte 29
Dearborn 28
Hyderabad 28
Redwood City 28
Turku 28
Abidjan 27
Bologna 27
Dong Ket 27
Hải Dương 27
Washington 27
Haiphong 26
Kish 25
Pune 25
Curitiba 24
San Francisco 24
Cattolica 23
Dammam 23
Hangzhou 23
Tashkent 23
Ankara 22
Fortaleza 22
Trieste 22
Brasília 21
Buenos Aires 21
Guangzhou 21
Totale 13.839
Salva come PNG Salva come JPEG
Nome #
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 526
Educational interventions alone and combined with port protector reduce the rate of central venous catheter infection and colonization in respiratory semi-intensive care unit. 436
Asthma in patients admitted to emergency department for COVID-19: prevalence and risk of hospitalization 309
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 232
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 231
Idiopathic Pulmonary Fibrosis: State of the Art for 2023 228
Post-COVID-19 global health strategies: the need for an interdisciplinary approach 227
Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage 216
Subclinical interstitial lung abnormalities: Lumping and splitting revisited 212
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 208
Efficacy and safety of nintedanib in patients with advanced idiopathic pulmonary fibrosis 205
Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study 201
A real-time integrated framework to support clinical decision making for covid-19 patients 198
Vaccines and Myocardial Injury in Patients Hospitalized for COVID-19 Infection: the CardioCOVID-Gemelli Study 197
Assessment of neurological manifestations in hospitalized patients with COVID-19 194
Balancing evidence and frontline experience in the early phases of the COVID-19 pandemic: current position of the Italian Society of Anti-infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 193
Demystifying fibrotic hypersensitivity pneumonitis diagnosis: it's all about shades of grey 192
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry 191
Residual respiratory impairment after COVID-19 pneumonia 190
Malnutrition in COVID-19 survivors: prevalence and risk factors 190
Differing severities of acute exacerbations of idiopathic pulmonary fibrosis (IPF): Insights from the INPULSIS® trials 188
Gemelli decision tree Algorithm to Predict the need for home monitoring or hospitalization of confirmed and unconfirmed COVID-19 patients (GAP-Covid19): preliminary results from a retrospective cohort study 186
Malnutrition in COVID-19 survivors: prevalence and risk factors 178
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 176
COVID-19 atypical Parsonage-Turner syndrome: a case report 174
Residual respiratory impairment after COVID-19 pneumonia 168
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 163
Reply to Moodley and to Ravaglia et al 163
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 163
Psychological Distress After Covid-19 Recovery: Reciprocal Effects With Temperament and Emotional Dysregulation. An Exploratory Study of Patients Over 60 Years of Age Assessed in a Post-acute Care Service 160
Lung ultrasonography for early management of patients with respiratory symptoms during COVID-19 pandemic 157
Sarilumab use in severe SARS-CoV-2 pneumonia 156
Obstructive sleep apnea in sarcoidosis and impact of cpap treatment on fatigue 155
Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: Pooled data from six clinical trials 152
Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial 151
Autophagy inhibition-mediated epithelial–mesenchymal transition augments local myofibroblast differentiation in pulmonary fibrosis 150
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 147
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia 147
Mediastinal lymph node enlargement in idiopathic pulmonary fibrosis: Relationships with disease progression and pulmonary function trends 146
Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis 144
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 144
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial 143
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI) 141
The characterisation of interstitial lung disease multidisciplinary team meetings: A global study 139
Chest CT Diagnosis and Clinical Management of Drug-related Pneumonitis in Patients Receiving Molecular Targeting Agents and Immune Checkpoint Inhibitors: A Position Paper from the Fleischner Society 139
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 134
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? 133
Agreement between chest ultrasonography and chest X-ray in patients who have undergone thoracic surgery: Preliminary results 132
Telemedicine-enabled, Hotel-based Management of Patients with COVID-19: A Single-Center Feasibility Study 130
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline 130
Severe asthma: One disease and multiple definitions 129
Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis 128
Digital lung auscultation: Will early diagnosis of fibrotic interstitial lung disease become a reality? 128
Challenges in COVID-19: is pulmonary thromboembolism related to overall severity? 127
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in children with household exposure to adults with COVID-19: Preliminary findings 126
Accuracy and Predictors of Success of EUS-B-FNA in the Diagnosis of Pulmonary Malignant Lesions: A Prospective Multicenter Italian Study 126
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done? 123
Molecular Testing in EBUS-TBNA Specimens of Lung Adenocarcinoma: A Study of Concordance Between Cell Block Method and Liquid-Based Cytology in Appraising Sample Cellularity and EGFR Mutations 122
Antibody-based therapies for idiopathic pulmonary fibrosis 122
Acute Respiratory Distress Syndrome and Lung Fibrosis Complicating Surgery in a Patient with Crohn's Disease 121
BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF) 119
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach 118
A randomized trial of pamrevlumab in patients with COVID-19 pneumonia 117
Fatigue in Covid-19 survivors: The potential impact of a nutritional supplement on muscle strength and function 117
Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper 117
Case of a 33-Year-Old Woman With Hemoptysis and Migrant Nodular Cavitary Lesions 116
Are newly launched pharmacotherapies efficacious in treating idiopathic pulmonary fibrosis? Or is there still more work to be done? 116
Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study 116
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants 115
Idiopathic pulmonary fibrosis 114
Antibody-based therapies for idiopathic pulmonary fibrosis 112
Observational, Multicenter Study on the Efficacy, Tolerability, and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis Older than 80 Years 111
Progressive Fibrosing Interstitial Lung Disease A Proposed Integrated Algorithm for Management 111
COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis 111
Current and Future Idiopathic Pulmonary Fibrosis Therapy 110
COVALENCE STUDY: Immunogenicity and Reactogenicity of a COVID-19 mRNA Vaccine in an Open-Label Cohort of Long-Survivor Patients with Metastatic Lung Cancer 109
Statin therapy and lung disorders 109
Home spirometry to assess efficacy of pirfenidone in progressive unclassifiable interstitial lung disease: better the devil you know than the devil you don't 109
Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression 108
Reliability of crackles in fibrotic interstitial lung disease: a prospective, longitudinal study 107
Ultrasonography of the Mediastinum: Techniques, Current Practice, and Future Directions 107
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study 106
Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis 106
Advances with pharmacotherapy for the treatment of interstitial lung disease 106
The management of Familial Pulmonary Fibrosis in different medical settings: Where does that leave us? An Italian nationwide survey 105
New frontiers in ultrasonography of the mediastinum: Pediatric EBUS-TBNA 104
Determinants and Evolution of Obstructive Sleep Apnea Syndrome After Myocardial Infarction 104
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis 104
Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative 103
COVID-19 and interstitial lung disease: Keep them separate 103
Treatment strategies for asthma: Reshaping the concept of asthma management 103
Reticulation is a Risk Factor of Progressive Subpleural non-Fibrotic Interstitial Lung Abnormalities 103
Nerandomilast in Patients with Progressive Pulmonary Fibrosis 102
Nintedanib in progressive fibrosing interstitial lung diseases 101
Multidisciplinary Evaluation of Interstitial Lung Diseases: New Opportunities Linked to Rheumatologist Involvement 101
Fibrotic Hypersensitivity Pneumonitis: Diagnosis and Management 100
The impact of fixed triple therapy with beclometasone/formoterol/glycopyrronium on health status and adherence in chronic obstructive pulmonary disease (COPD) in an italian context of real life: The TRITRIAL study protocol 99
Ultrasound-guided needle aspiration biopsy of isolated anterior mediastinal masses 98
Early diagnosis of idiopathic pulmonary fibrosis: Closer to the goal? 98
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond 98
Totale 14.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 113.214
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 113.214
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 0 0 0 0 0 72 75
2021/20221.506 141 75 29 155 56 48 30 237 61 68 339 267
2022/20232.924 315 302 274 430 270 355 136 179 310 147 132 74
2023/20242.037 69 436 91 100 102 211 136 75 90 149 234 344
2024/20254.633 121 97 362 202 306 208 220 229 751 411 923 803
2025/202612.134 1.672 551 971 1.706 2.025 630 1.974 695 937 922 51 0
Totale 25.480